R-61837
R-61837 is a synthetic antirhinoviral compound with significant in vitro activity. R-61837 is 10 times and 57 times more active against human rhinovirus type 9 (HRV-9) than Enviroxime and dichloroflavone (DCF), respectively, and is more active against human rhinovirus type 2 (HRV-2) were 5 times and 10 times higher respectively[1].
Product Specifications
CAS Number
[100241-46-1]
UNSPSC
12352005
Target
Enterovirus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/r-61837.html
Smiles
CC1=CC=CC(N2CCN(C3=CC=C(OC)N=N3)CC2)=C1
Molecular Formula
C16H20N4O
Molecular Weight
284.36
References & Citations
[1]Al-Nakib W, et al. A ‘new’generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions[J]. Antiviral research, 1987, 8 (4) : 179-187.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![PD1 (PDCD1) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI12G4]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
TA807868AM 100 µL
PD1 (PDCD1) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI12G4]
Ask
View Details 
MBS1079099-01 0.02 mg (E-Coli)
Recombinant Haemophilus influenzae 1,4-Dihydroxy-2-naphthoyl-CoA synthase (menB)
Ask
View Details 
MBS1079099-02 0.02 mg (Yeast)
Recombinant Haemophilus influenzae 1,4-Dihydroxy-2-naphthoyl-CoA synthase (menB)
Ask
View Details MBS1079099-03 0.1 mg (E-Coli)
Recombinant Haemophilus influenzae 1,4-Dihydroxy-2-naphthoyl-CoA synthase (menB)
Ask
View Details MBS1079099-04 0.1 mg (Yeast)
Recombinant Haemophilus influenzae 1,4-Dihydroxy-2-naphthoyl-CoA synthase (menB)
Ask
View Details MBS1079099-05 0.02 mg (Baculovirus)
Recombinant Haemophilus influenzae 1,4-Dihydroxy-2-naphthoyl-CoA synthase (menB)
Ask
View Details